Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #101 to #350.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Activity median thermodynamic diameter‏‎ (3 revisions)
  2. Voxel phantom‏‎ (3 revisions)
  3. Growth fraction‏‎ (3 revisions)
  4. Organ dose equivalent‏‎ (3 revisions)
  5. ICRP Publication 103‏‎ (3 revisions)
  6. Excretion rate (instantaneous)‏‎ (3 revisions)
  7. Extrathoracic airways‏‎ (3 revisions)
  8. Galactic cosmic radiation‏‎ (3 revisions)
  9. Growth hormone (somatotropin)‏‎ (3 revisions)
  10. Recovery‏‎ (3 revisions)
  11. DNA damage signalling‏‎ (3 revisions)
  12. Spread-out Bragg peak‏‎ (3 revisions)
  13. Fairness‏‎ (3 revisions)
  14. Absorption‏‎ (3 revisions)
  15. Gamma ray‏‎ (3 revisions)
  16. Biomedical research volunteer‏‎ (3 revisions)
  17. Cardiomyopathy‏‎ (3 revisions)
  18. Dose equivalent‏‎ (3 revisions)
  19. Field-size effect (Volume effect)‏‎ (3 revisions)
  20. Gastrointestinal syndrome‏‎ (3 revisions)
  21. Wisdom‏‎ (3 revisions)
  22. Autonomy‏‎ (3 revisions)
  23. Dose limit‏‎ (3 revisions)
  24. Target region‏‎ (3 revisions)
  25. Flexible tissues‏‎ (3 revisions)
  26. Guide to the System of Radiological Protection‏‎ (3 revisions)
  27. Constancy test‏‎ (3 revisions)
  28. Dose‏‎ (3 revisions)
  29. Dose limits‏‎ (3 revisions)
  30. Fluence‏‎ (3 revisions)
  31. Potential exposure‏‎ (3 revisions)
  32. DS02‏‎ (3 revisions)
  33. Fluoroscopically guided interventions‏‎ (3 revisions)
  34. Annual dose‏‎ (3 revisions)
  35. Cell death‏‎ (3 revisions)
  36. Contamination‏‎ (3 revisions)
  37. Rigidity threshold‏‎ (3 revisions)
  38. Dose of record (E)‏‎ (3 revisions)
  39. Low Earth orbit‏‎ (3 revisions)
  40. Accountability‏‎ (3 revisions)
  41. X ray‏‎ (3 revisions)
  42. Half-life, physical‏‎ (3 revisions)
  43. Annual limit on intake‏‎ (3 revisions)
  44. Exponential survival curve‏‎ (3 revisions)
  45. Unsealed source‏‎ (3 revisions)
  46. Xerostomia‏‎ (3 revisions)
  47. Public exposure‏‎ (3 revisions)
  48. Dose per content function‏‎ (3 revisions)
  49. Interphase death‏‎ (3 revisions)
  50. Equity‏‎ (3 revisions)
  51. Test‏‎ (3 revisions)
  52. Graded approach‏‎ (3 revisions)
  53. Fractionation‏‎ (3 revisions)
  54. Uptake‏‎ (3 revisions)
  55. Active (red) bone marrow‏‎ (3 revisions)
  56. Utilitarian ethics‏‎ (3 revisions)
  57. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  58. Operational quantity‏‎ (3 revisions)
  59. Coster-Kronig transition‏‎ (3 revisions)
  60. Value judgement‏‎ (3 revisions)
  61. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  62. High level waste‏‎ (2 revisions)
  63. Clearance‏‎ (2 revisions)
  64. Deontological Ethics‏‎ (2 revisions)
  65. Repopulation‏‎ (2 revisions)
  66. Differentiation‏‎ (2 revisions)
  67. Routine monitoring‏‎ (2 revisions)
  68. ICRPædia Guide to Radon‏‎ (2 revisions)
  69. Special (non-routine) monitoring‏‎ (2 revisions)
  70. Lifetime risk‏‎ (2 revisions)
  71. Macrophage colony stimulating factor‏‎ (2 revisions)
  72. Multiplicative risk projection model‏‎ (2 revisions)
  73. Activity‏‎ (2 revisions)
  74. Beta-minus decay‏‎ (2 revisions)
  75. Clearance level‏‎ (2 revisions)
  76. Radiographer‏‎ (2 revisions)
  77. Representative organism (non-human biota)‏‎ (2 revisions)
  78. ICRPædia Guide to the Basics of Ionising Radiation‏‎ (2 revisions)
  79. Dose constraint‏‎ (2 revisions)
  80. Early normal tissue responses‏‎ (2 revisions)
  81. Threshold dose for tissue reactions‏‎ (2 revisions)
  82. Magnetosphere‏‎ (2 revisions)
  83. Pharynx‏‎ (2 revisions)
  84. Beta-plus decay‏‎ (2 revisions)
  85. Calculating Doses from Intakes of Radionuclides‏‎ (2 revisions)
  86. Cumulative dose‏‎ (2 revisions)
  87. Representative person‏‎ (2 revisions)
  88. Safety‏‎ (2 revisions)
  89. Dose conversion coefficient‏‎ (2 revisions)
  90. Edema‏‎ (2 revisions)
  91. Specific effective energy‏‎ (2 revisions)
  92. Limitation of dose‏‎ (2 revisions)
  93. Excess relative risk‏‎ (2 revisions)
  94. Exposure situation‏‎ (2 revisions)
  95. Transmission detection system‏‎ (2 revisions)
  96. Multistage tumorigenesis‏‎ (2 revisions)
  97. Non-sphericity parameter‏‎ (2 revisions)
  98. Growth factor‏‎ (2 revisions)
  99. Alimentary tract transfer factor‏‎ (2 revisions)
  100. Hormones‏‎ (2 revisions)
  101. Authorization‏‎ (2 revisions)
  102. Procedural values‏‎ (2 revisions)
  103. Clonogenic cells‏‎ (2 revisions)
  104. Curie‏‎ (2 revisions)
  105. Reproductive integrity‏‎ (2 revisions)
  106. Safety case‏‎ (2 revisions)
  107. Slow repair‏‎ (2 revisions)
  108. Effect Dose 50‏‎ (2 revisions)
  109. Isotropic geometry‏‎ (2 revisions)
  110. Endogeneous excretion‏‎ (2 revisions)
  111. Lineal energy‏‎ (2 revisions)
  112. Thyroid blocking‏‎ (2 revisions)
  113. Exposure to Radon at Home‏‎ (2 revisions)
  114. Transparency‏‎ (2 revisions)
  115. GATA binding protein 2‏‎ (2 revisions)
  116. Waste disposal‏‎ (2 revisions)
  117. Non-targeted effects‏‎ (2 revisions)
  118. Hounsfield unit‏‎ (2 revisions)
  119. Authorized limit‏‎ (2 revisions)
  120. Planned exposure situation‏‎ (2 revisions)
  121. Progenitor cell‏‎ (2 revisions)
  122. Cardiac arrhythmias‏‎ (2 revisions)
  123. Radiation belt‏‎ (2 revisions - redirect page)
  124. Clonogenic survival‏‎ (2 revisions)
  125. Reasonableness‏‎ (2 revisions)
  126. Cytokines‏‎ (2 revisions)
  127. Residual dose‏‎ (2 revisions)
  128. Safety culture‏‎ (2 revisions)
  129. Solar cosmic radiation‏‎ (2 revisions)
  130. Inhalability‏‎ (2 revisions)
  131. Spontaneous fission‏‎ (2 revisions)
  132. Itinerant (radiation) worker‏‎ (2 revisions)
  133. Linear-non-threshold model‏‎ (2 revisions)
  134. Trapped particles‏‎ (2 revisions)
  135. Acute radiation syndrome‏‎ (2 revisions)
  136. Orphan source‏‎ (2 revisions)
  137. Autoimmune disease‏‎ (2 revisions)
  138. Platelet-derived growth factor‏‎ (2 revisions)
  139. ICRP Publication 118‏‎ (2 revisions)
  140. Cardiac valve diseases‏‎ (2 revisions)
  141. Radiation modifier‏‎ (2 revisions)
  142. Radiological protection principles‏‎ (2 revisions)
  143. Respiratory protection‏‎ (2 revisions)
  144. Disposal‏‎ (2 revisions)
  145. Scintigraphy‏‎ (2 revisions)
  146. Dose criteria‏‎ (2 revisions)
  147. Solar cycle‏‎ (2 revisions)
  148. Inner bremsstrahlung‏‎ (2 revisions)
  149. Environmental exposure‏‎ (2 revisions)
  150. Systemic model‏‎ (2 revisions)
  151. Linear-quadratic dose response model‏‎ (2 revisions)
  152. Exempt waste‏‎ (2 revisions)
  153. Time factor‏‎ (2 revisions)
  154. Myocardial perfusion‏‎ (2 revisions)
  155. Adaptive response‏‎ (2 revisions)
  156. What is Radon?‏‎ (2 revisions)
  157. Alveolar-interstitial region‏‎ (2 revisions)
  158. Projected dose‏‎ (2 revisions)
  159. Co-expertise‏‎ (2 revisions)
  160. Radionuclides of natural origin‏‎ (2 revisions)
  161. Connective tissue‏‎ (2 revisions)
  162. Recovery (cellular or tissue)‏‎ (2 revisions)
  163. DRL process‏‎ (2 revisions)
  164. Retrievability‏‎ (2 revisions)
  165. Immune system‏‎ (2 revisions)
  166. Institutional control‏‎ (2 revisions)
  167. Stakeholder‏‎ (2 revisions)
  168. Environmental radiation protection‏‎ (2 revisions)
  169. Tachycardia‏‎ (2 revisions)
  170. Exemption level‏‎ (2 revisions)
  171. Tissue equivalent material‏‎ (2 revisions)
  172. Myocardial stress test‏‎ (2 revisions)
  173. Oversight‏‎ (2 revisions)
  174. Hyperbaric oxygen‏‎ (2 revisions)
  175. Bioturbation‏‎ (2 revisions)
  176. Cardioverter-defibrillator‏‎ (2 revisions)
  177. Radiation safety officer‏‎ (2 revisions)
  178. Radioresponsiveness‏‎ (2 revisions)
  179. Consequential late effects‏‎ (2 revisions)
  180. Recovery responder‏‎ (2 revisions)
  181. Reversibility‏‎ (2 revisions)
  182. In vivo radiobioassay‏‎ (2 revisions)
  183. Solar particle event‏‎ (2 revisions)
  184. Effective dose equivalent‏‎ (2 revisions)
  185. Existing exposure situation‏‎ (2 revisions)
  186. Gastroschisis‏‎ (2 revisions)
  187. Worker‏‎ (2 revisions)
  188. Nuclear track detectors‏‎ (2 revisions)
  189. Angiogenesis‏‎ (2 revisions)
  190. Particle radiance‏‎ (2 revisions)
  191. Hyperfractionation‏‎ (2 revisions)
  192. Bone marrow‏‎ (2 revisions)
  193. Protection strategy‏‎ (2 revisions)
  194. Radiation source‏‎ (2 revisions)
  195. Cohort study‏‎ (2 revisions)
  196. Radiosensitiser‏‎ (2 revisions)
  197. DRL value‏‎ (2 revisions)
  198. Rehabilitation of living conditions‏‎ (2 revisions)
  199. Right to know‏‎ (2 revisions)
  200. Incidence‏‎ (2 revisions)
  201. Solar wind‏‎ (2 revisions)
  202. Epithelium‏‎ (2 revisions)
  203. Target tissue‏‎ (2 revisions)
  204. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  205. Acceptance test‏‎ (2 revisions)
  206. Gastrulation‏‎ (2 revisions)
  207. Working level‏‎ (2 revisions)
  208. OLINDA/EXM‏‎ (2 revisions)
  209. Habitual mouth breather‏‎ (2 revisions)
  210. Annihilation photons‏‎ (2 revisions)
  211. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  212. Background dose (rate)‏‎ (2 revisions)
  213. Radiosensitivity, cellular‏‎ (2 revisions)
  214. Containment‏‎ (2 revisions)
  215. Rigidity‏‎ (2 revisions)
  216. Dose-length product‏‎ (2 revisions)
  217. Security‏‎ (2 revisions)
  218. Incident‏‎ (2 revisions)
  219. Intermediate level waste‏‎ (2 revisions)
  220. Stenosis‏‎ (2 revisions)
  221. Equieffective dose‏‎ (2 revisions)
  222. Local DRL‏‎ (2 revisions)
  223. Expanded and aligned radiation field‏‎ (2 revisions)
  224. Tolerability‏‎ (2 revisions)
  225. Medical exposure‏‎ (2 revisions)
  226. Naturally occurring radioactive material‏‎ (2 revisions)
  227. Adventitious‏‎ (2 revisions)
  228. Working level month‏‎ (2 revisions)
  229. Habitual nose breather‏‎ (2 revisions)
  230. Patient entrance reference point‏‎ (2 revisions)
  231. Hypoplasia‏‎ (2 revisions)
  232. Backscatter detection system‏‎ (2 revisions)
  233. Potential recoverability correction factor‏‎ (2 revisions)
  234. Bradycardia‏‎ (2 revisions)
  235. Protective action guide‏‎ (2 revisions)
  236. Radiation worker‏‎ (2 revisions)
  237. Detriment‏‎ (2 revisions)
  238. Dose-rate effect‏‎ (2 revisions)
  239. Inclusiveness‏‎ (2 revisions)
  240. Source-related‏‎ (2 revisions)
  241. Internal conversion electron‏‎ (2 revisions)
  242. Electron-capture decay‏‎ (2 revisions)
  243. LD 50/30‏‎ (2 revisions)
  244. Telangiectasia‏‎ (2 revisions)
  245. Member of the public‏‎ (2 revisions)
  246. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  247. Unattached fraction‏‎ (2 revisions)
  248. Necrosis‏‎ (2 revisions)
  249. Hazard‏‎ (2 revisions)
  250. Peak skin dose‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)